313 related articles for article (PubMed ID: 7685416)
21. Regulation of the enzymatic activity of prostate-specific antigen and its reactions with extracellular protease inhibitors in prostate cancer.
Lilja H
Scand J Clin Lab Invest Suppl; 1995; 220():47-56. PubMed ID: 7544478
[TBL] [Abstract][Full Text] [Related]
22. Reference ranges for the concentrations of total and complexed plasma prostate-specific antigen and their ratio in patients with benign prostate hyperplasia.
España F; Martínez M; Royo M; Vera CD; Estellés A; Aznar J; Jiménez-Cruz JF
Eur Urol; 1997; 32(3):268-72. PubMed ID: 9358211
[TBL] [Abstract][Full Text] [Related]
23. Advantages of replacing the total PSA assay with the assay for PSA-alpha 1-antichymotrypsin complex for the screening and management of prostate cancer.
Wu JT; Liu GH
J Clin Lab Anal; 1998; 12(1):32-40. PubMed ID: 9484667
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer.
Okihara K; Cheli CD; Partin AW; Fritche HA; Chan DW; Sokoll LJ; Brawer MK; Schwartz MK; Vessella RL; Loughlin KR; Johnston DA; Babaian RJ
J Urol; 2002 May; 167(5):2017-23; discussion 2023-4. PubMed ID: 11956430
[TBL] [Abstract][Full Text] [Related]
25. Value of the serum prostate-specific antigen-alpha 1-antichymotrypsin complex and its density as a predictor for the extent of prostate cancer.
Hara I; Miyake H; Hara S; Yamanaka N; Ono Y; Eto H; Takechi Y; Arakawa S; Kamidono S
BJU Int; 2001 Jul; 88(1):53-7. PubMed ID: 11446846
[TBL] [Abstract][Full Text] [Related]
26. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis.
Lein M; Jung K; Elgeti U; Brux B; Sinha P; Schnorr D; Loening SA
Anticancer Res; 2000; 20(6D):4997-5001. PubMed ID: 11326657
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a two-site immunoradiometric assay for measuring noncomplexed (free) prostate-specific antigen.
Cuny C; Pham L; Kramp W; Sharp T; Soriano TF
Clin Chem; 1996 Aug; 42(8 Pt 1):1243-9. PubMed ID: 8697584
[TBL] [Abstract][Full Text] [Related]
28. Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy.
Lilja H; Haese A; Björk T; Friedrich MG; Piironen T; Pettersson K; Huland E; Huland H
J Urol; 1999 Dec; 162(6):2029-34; discussion 2034-5. PubMed ID: 10569562
[TBL] [Abstract][Full Text] [Related]
29. A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis.
Lein M; Jung K; Hammerer P; Graefen M; Semjonow A; Stieber P; Ossendorf M; Luboldt HJ; Brux B; Stephan C; Schnorr D; Loening SA
Prostate; 2001 May; 47(2):77-84. PubMed ID: 11340629
[TBL] [Abstract][Full Text] [Related]
30. Analysis of free prostate-specific antigen (PSA) after chemical release from the complex with alpha(1)-antichymotrypsin (PSA-ACT).
Peter J; Unverzagt C; Hoesel W
Clin Chem; 2000 Apr; 46(4):474-82. PubMed ID: 10759471
[TBL] [Abstract][Full Text] [Related]
31. Individual prostate-specific antigen (PSA) forms as prostate tumor markers.
Becker C; Lilja H
Clin Chim Acta; 1997 Jan; 257(1):117-32. PubMed ID: 9028629
[TBL] [Abstract][Full Text] [Related]
32. Technicon Immuno 1 PSA assay measures both free and alpha-1-antichymotrypsin-complexed prostate-specific antigen on an equimolar basis.
Zhou Z; Ng PC; Very DL; Allard WJ; Yeung KK
J Clin Lab Anal; 1996; 10(3):155-9. PubMed ID: 8731504
[TBL] [Abstract][Full Text] [Related]
33. [Changes in the levels of prostate-specific antigen and its molecular forms with alpha 1-antichymotrypsin in patients with benign prostatic hyperplasia].
Grigor'ev ME; Mazo EB; Chekhonin VP
Urol Nefrol (Mosk); 1998; (4):33-7. PubMed ID: 9727319
[TBL] [Abstract][Full Text] [Related]
34. Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer.
Stenman UH; Hakama M; Knekt P; Aromaa A; Teppo L; Leinonen J
Lancet; 1994 Dec; 344(8937):1594-8. PubMed ID: 7527116
[TBL] [Abstract][Full Text] [Related]
35. Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassay.
Wang TJ; Linton HJ; Payne J; Rittenhouse HG; Chan DW; Partin AW; Wolfert RL; Kuus-Reichel K
Hybridoma; 1999 Dec; 18(6):535-41. PubMed ID: 10626683
[TBL] [Abstract][Full Text] [Related]
36. Serum prostate specific antigen binding alpha 1-antichymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones.
Stamey TA; Chen Z; Prestigiacomo A
J Urol; 1994 Nov; 152(5 Pt 1):1510-4. PubMed ID: 7523708
[TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of serum prostate-specific antigen-alpha1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative study.
Kuriyama M; Ueno K; Uno H; Kawada Y; Akimoto S; Noda M; Nasu Y; Tsushima T; Ohmori H; Sakai H; Saito Y; Meguro N; Usami M; Kotake T; Suzuki Y; Arai Y; Shimazaki J
Int J Urol; 1998 Jan; 5(1):48-54. PubMed ID: 9535601
[TBL] [Abstract][Full Text] [Related]
38. PSA-alpha 1-antichymotrypsin determination in patients with benign prostatic hyperplasia and prostatic cancer.
Bogni A; Seregni ET; Abregú AV; Boni R; Bombardieri E
Int J Biol Markers; 1993; 8(2):138-9. PubMed ID: 7690059
[No Abstract] [Full Text] [Related]
39. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
[TBL] [Abstract][Full Text] [Related]
40. Measurement of the complex between prostate-specific antigen and alpha1-protease inhibitor in serum.
Zhang WM; Finne P; Leinonen J; Vesalainen S; Nordling S; Stenman UH
Clin Chem; 1999 Jun; 45(6 Pt 1):814-21. PubMed ID: 10351990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]